GSK sells Lucozade and Ribena to Suntory

9 September 2013 - Deborah Wilkes

Archived

GlaxoSmithKline has agreed to sell its Lucozade and Ribena nutritional drinks brands to Japan's Suntory Beverage & Food for £1.35 billion (US$2.15 billion) in cash.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: